Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation.
about
Management of immunosuppressant agents following liver transplantation: Less is moreMitochondria, endothelial cell function, and vascular diseases.Different influences on tacrolimus pharmacokinetics by coadministrations of zhi ke and zhi shi in ratsEfficacy and safety of midodrine in the treatment of dialysis-associated hypotension.The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients.Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing.Factors Associated with Uncontrolled Hypertension among Renal Transplant Recipients Attending Nephrology Clinics in Nairobi, Kenya.Management of the well renal transplant recipient: outpatient surveillance and treatment recommendations.Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival.Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension.Secondary hypertension: interfering substances.Renal primary cilia lengthen after acute tubular necrosis.The impact of pancreas and kidney transplant on cardiovascular risk factors (analyzed by mode of immunosuppression and exocrine drainage).Hypertension in kidney transplant recipients.Formulation strategies for drug delivery of tacrolimus: An overview.Contrast-induced acute kidney injury in kidney transplant recipients: A systematic review and meta-analysis.Tacrolimus and sirolimus decrease oxidative phosphorylation of isolated rat kidney mitochondria.Efficacy and safety of early tacrolimus conversion to sirolimus after kidney transplantation: Long-term results of a prospective randomized study.Comparing antihypertensive effect and plasma ciclosporin concentration between amlodipine and valsartan regimens in hypertensive renal transplant patients receiving ciclosporin therapy.Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.Conversion to sirolimus in renal transplant recipients: a single-center experience.Comparative effects of sirolimus and cyclosporin on conduit arteries endothelial function in kidney recipients.Sirolimus-based calcineurin inhibitor withdrawal immunosuppressive regimen in kidney transplantation: a single center experience.Preservation of graft function in low-risk living kidney transplant recipients treated with a combination of sirolimus and cyclosporine.Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients.Comprehensive review of cardiovascular toxicity of drugs and related agents.
P2860
Q26770033-83F9F41F-C8D2-4894-BFB3-2FEEF290BD28Q33600464-6872628F-45A6-4A40-8D95-C1BDB78DBE8EQ34557606-4A4EDACE-3BDC-4108-B65A-7BBF8C877D6CQ35194439-52142583-E751-4788-8864-B8B0787E1481Q35612903-78EFE28C-BFFC-41DA-9EF4-9FE01FF49674Q35782898-613DC408-9208-4FAF-9C4D-9B0D6CEB7AABQ35898088-A91AF411-06E6-4C86-8345-1293EC8815E2Q36362771-A26E7126-C969-443C-BE22-56D5EE730B6DQ36662099-05CCED70-FA71-4936-9501-3B9EDFA15064Q36686822-F0F71A88-7EFA-4CC1-9736-FE097137C8BAQ37209318-B9F46F02-CDE7-482C-9F26-0825E44C1AD5Q37367710-F830524D-C1FC-4345-A585-6872BA9EDA6BQ37592272-1BD885A4-4972-4157-BAF6-3A39C444C6C4Q37850471-44CA8338-D4F2-4B0A-8BF7-C58F0549DA4DQ38098512-920BCBCC-8987-4720-86CA-AE588D1C1204Q38915830-2A6FD859-48A1-4378-B702-C9DBC070DB6AQ41787336-02011611-50CD-4BD9-B8B3-1B3D58FC26B6Q42328635-A912183A-4422-4370-AE9A-6C8407C63E3BQ42723097-A4CA2FD0-F994-4773-809E-9769D67E0A86Q42928039-84D92894-EA80-4735-B1B5-C166A64BC5A6Q42975028-954E6857-623D-46E3-B16A-1E9B0024D900Q43034436-9DE9EBBC-77C0-41E2-87E7-1BF9D3716C7EQ43128472-84CEBC86-8584-49D4-8371-BCBD148149DDQ45034693-F6C25818-34F2-47FC-AA60-40C2EDE49CA3Q45363560-7CF2CEC8-6037-439A-9934-CFC8B50FAF51Q47556269-D310EE14-CAD1-4771-B3D0-13582D8D9752
P2860
Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Influence of cyclosporin, tacr ...... n after renal transplantation.
@ast
Influence of cyclosporin, tacr ...... n after renal transplantation.
@en
Influence of cyclosporin, tacr ...... n after renal transplantation.
@nl
type
label
Influence of cyclosporin, tacr ...... n after renal transplantation.
@ast
Influence of cyclosporin, tacr ...... n after renal transplantation.
@en
Influence of cyclosporin, tacr ...... n after renal transplantation.
@nl
prefLabel
Influence of cyclosporin, tacr ...... n after renal transplantation.
@ast
Influence of cyclosporin, tacr ...... n after renal transplantation.
@en
Influence of cyclosporin, tacr ...... n after renal transplantation.
@nl
P2093
P356
P1476
Influence of cyclosporin, tacr ...... n after renal transplantation.
@en
P2093
P304
P356
10.1093/NDT/16.SUPPL_1.121
P407
P478
16 Suppl 1
P577
2001-01-01T00:00:00Z